https://pubmed.ncbi.nlm.nih.gov/38115936
The abstract is a commentary on a study in the Journal of Hepatology that suggests tenofovir disoproxil fumarate may be more effective than entecavir in preventing hepatocellular carcinoma in patients with chronic hepatitis B, but notes the need for further research due to study limitations.